Learn More
Medchemexpress LLC Doxazosin mesylate | 77883-43-3 | 98.5% | C24H29N5O8S | 1 ML

Supplier: Medchemexpress LLC HYB0098A10MM/1ML
Doxazosin mesylate is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors. It is the mesylate salt form of doxazosin, a long-lasting inhibitor of α1-adrenoceptors widely used to treat benign prostatic hyperplasia and lower urinary tract symptoms. It may also have a direct inhibitory effect on cholesterol synthesis, potentially leading to upregulation of the LDL receptor and a reduction in LDL cholesterol.
- Selectively antagonizes postsynaptic α1-adrenergic receptors
- Long-lasting inhibitor of α1-adrenoceptors
- Used to treat benign prostatic hyperplasia and lower urinary tract symptoms
- May have a direct inhibitory effect on cholesterol synthesis
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.